Archives
-
Diclofenac: Non-Selective COX Inhibitor Guide
2026-09-16
Diclofenac is a non-selective COX inhibitor used to reduce prostaglandin production in inflammation and pain signaling research. This guide connects its biochemical activity with human pluripotent stem cell-derived intestinal organoid models while defining solvent, storage, assay, and interpretation limits.
-
5-Methyl-CTP: From Transcript Design to Translation
2026-09-16
A translational framework for using 5-Methyl-CTP to improve mRNA design while recognizing that transcript chemistry, delivery, antigen presentation, and experimental validation must be optimized as one system.
-
Patient-Derived Gastric Cancer Assembloids
2026-09-15
A 2025 study developed patient-derived gastric cancer assembloids by combining matched tumor organoids with tumor-derived stromal subpopulations, including fibroblasts, mesenchymal stem cells, and endothelial cells. The model altered gene-expression programs and drug responses relative to monocultures, providing a more physiologically relevant platform for studying tumor–stroma interactions, resistance, and personalized treatment strategies.
-
Masitinib (AB1010): KIT/PDGFR Workflow Guide
2026-09-15
Masitinib (AB1010) provides a DMSO-compatible way to investigate KIT and PDGFRα/β inhibition in cancer biology, mastocytosis research, and inflammatory cell models. It is not suitable for aqueous or ethanol-based workflows, broad-spectrum kinase profiling, or direct clinical treatment conclusions.
-
RSV NS3 Phosphorylation Rewires Host Signaling
2026-09-14
Zhuang et al. show that Rice stripe virus NS3 changes function during infection by interacting with and being phosphorylated through the OsSnRK3.25 pathway. This stage-dependent control links antiviral RNA interference, reactive oxygen species, programmed cell death, pathogenicity, and vector transmission in a co-survival model spanning rice and the planthopper vector.
-
Epacadostat Workflow for IDO1 Immunometabolism
2026-09-14
Epacadostat (INCB024360) enables a practical bridge between IDO1 biochemistry, standardized whole-blood stimulation, and tumor-immune modeling. This workflow emphasizes solvent control, orthogonal metabolic readouts, donor-aware cytokine analysis, and rational PD-1/PD-L1 checkpoint inhibitor combination testing.
-
Protease Inhibitor Cocktail for Plant Extracts
2026-09-13
Protect fragile plant proteins during extraction, immunoblotting, co-immunoprecipitation, and kinase assays with broad-spectrum, EDTA-free inhibition. This workflow connects better protein preservation to mechanistic studies of NSP2–MYB40 control of flavonoid biosynthesis and symbiotic signaling.
-
Toremifene Workflows for Prostate Cancer Research
2026-09-12
Toremifene provides a practical pharmacological probe for estrogen receptor modulation, hormone-responsive cancer research, and cell-growth phenotyping. This workflow extends standard SERM testing with calcium-entry, STIM1 stability, migration, and bone-metastasis assays inspired by a mechanistic prostate cancer study.
-
PreScission Protease (PSP): Practical Tag Cleavage
2026-09-11
PreScission Protease (PSP), an HRV 3C protease fusion enzyme, is used for sequence-directed removal of affinity tags from recombinant proteins under low-temperature conditions. It is appropriate when the defined cleavage sequence is present and accessible, but should not be selected for noncanonical sites, broad-spectrum proteolysis, or workflows that require high-temperature activity.
-
UBR1 and UBR2 in Mammalian ER Stress Sensing
2026-09-11
The reference study identifies the N-recognin E3 ligases UBR1 and UBR2 as stress-responsive regulators of mammalian protein quality control. Its findings connect N-degron pathway activity with ER-associated degradation and show that loss of both ligases increases susceptibility to ER stress-induced apoptosis, while stress stabilizes the proteins as a potential adaptive response.
-
5-Methyl-CTP: A Translational Lever for mRNA
2026-09-10
5-Methyl-CTP connects nucleotide chemistry with mRNA stability, translation, and delivery strategy. This thought-leadership article interprets evidence from OMV-mediated tumor vaccination and offers a practical framework for evaluating modified transcripts in translational workflows.
-
Hoechst 33342 for GERD Cell Assays
2026-09-10
Hoechst 33342 converts nuclear morphology and cell-count normalization into practical readouts for bile-acid-stressed esophageal epithelial models. This guide connects a live-cell-permeant bis-benzimidazole fluorescent dye to the TAS2R38/TRPV1 GERD workflow while separating what fluorescence can measure from what requires orthogonal molecular assays.
-
5-Methyl-CTP for Better mRNA Synthesis
2026-09-09
Build more deliberate mRNA synthesis workflows by testing 5-Methyl-CTP as a cytidine substitute for transcript stability and translation-focused assays. The workflow also shows how modified RNA can be paired cautiously with vesicle-based antigen delivery concepts from a personalized tumor-vaccine study.
-
Patient-Derived Gastric Cancer Assembloids
2026-09-09
Shapira-Netanelov and colleagues developed patient-derived gastric cancer assembloids by combining matched tumor organoids with tumor-derived stromal subpopulations. The model reproduced clinically relevant tumor–stroma interactions and revealed that stromal composition can substantially alter gene expression and therapeutic response, supporting more informative personalized drug screening.
-
D-Luciferin Sodium Salt for CAR-M Assays
2026-09-08
D-Luciferin sodium salt enables ATP-dependent bioluminescence assays that can connect CAR-macrophage engineering with longitudinal tumor and cell-state measurements. This article explains how to interpret firefly luciferase signals without confusing reporter output with direct immune function or tumor burden.